Triazole compounds that modulate HSP90 activity
US9539243B2 · kind B2 · utility
2Cited by
45References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2015 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Jan 7, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a pharmaceutical composition comprising such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.